{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:20:44Z","timestamp":1792092044896,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02208-3","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:19:10Z","timestamp":1774570750000},"page":"2799-2818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticle embedded dot matrix transdermal patches: a novel approach for targeted and controlled drug delivery in rheumatoid arthritis"],"prefix":"10.1007","volume":"34","author":[{"family":"Devanshu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saahil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Jhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2208_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/nano12244494","author":"O Afzal","year":"2022","unstructured":"Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, Mubeen B, Murtaza BN, Iftikhar S, Riaz N, Kazmi I (2022) Nanoparticles in drug delivery: from history to therapeutic applications. Nanomaterials. https:\/\/doi.org\/10.3390\/nano12244494","journal-title":"Nanomaterials"},{"issue":"2","key":"2208_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.21276\/ijlssr.2018.4.2.17","volume":"4","author":"M Agarwal","year":"2018","unstructured":"Agarwal M, Agarwal MK, Shrivastav N, Pandey S, Das R, Gaur P (2018) Preparation of chitosan nanoparticles and their in-vitro characterization. Int J Life-Sci Sci Res 4(2):1713\u20131720. https:\/\/doi.org\/10.21276\/ijlssr.2018.4.2.17","journal-title":"Int J Life-Sci Sci Res"},{"key":"2208_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA J Am Med Assoc 320:1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA J Am Med Assoc"},{"key":"2208_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1155622","author":"KA Altammar","year":"2023","unstructured":"Altammar KA (2023) A review on nanoparticles: characteristics, synthesis, applications, and challenges. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1155622","journal-title":"Front Microbiol"},{"key":"2208_CR5","doi-asserted-by":"publisher","first-page":"115325","DOI":"10.1016\/j.addr.2024.115325","volume":"209","author":"X An","year":"2024","unstructured":"An X, Yang J, Cui X, Zhao J, Jiang C, Tang M, Dong Y, Lin L, Li H, Wang F (2024) Advances in local drug delivery technologies for improved rheumatoid arthritis therapy. Adv Drug Deliv Rev 209:115325","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2208_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.37532\/0974-7427.2023.17(1).177","volume":"17","author":"MN Anusha","year":"2023","unstructured":"Anusha MN, Babu NA, Masthan K (2023) Nanodrug delivery systems: a review. Review Article 17(1):177. https:\/\/doi.org\/10.37532\/0974-7427.2023.17(1).177","journal-title":"Review Article"},{"issue":"4","key":"2208_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1039\/d4pm00085d","volume":"1","author":"MMFA Baig","year":"2024","unstructured":"Baig MMFA, Kwan CH, Wu H, Chair SY (2024) The etiology, pathogenesis, treatment, and development of transdermal drug delivery systems for rheumatoid arthritis. RSC Pharm 1(4):592\u2013607. https:\/\/doi.org\/10.1039\/d4pm00085d","journal-title":"RSC Pharm"},{"key":"2208_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ma15196521","author":"SM Bashir","year":"2022","unstructured":"Bashir SM, Ahmed Rather G, Patr\u00edcio A, Haq Z, Sheikh AA, Shah MZU, Singh H, Khan AA, Imtiyaz S, Ahmad SB, Nabi S, Rakhshan R, Hassan S, Fonte P (2022) Chitosan nanoparticles: a versatile platform for biomedical applications. Materials. https:\/\/doi.org\/10.3390\/ma15196521","journal-title":"Materials"},{"issue":"7","key":"2208_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M, Mart\u00ednez G, Merinero M, Arg\u00fcelles-Arias F, Alcudia A (2020) Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials 10(7):1\u201341. https:\/\/doi.org\/10.3390\/nano10071403","journal-title":"Nanomaterials"},{"key":"2208_CR10","doi-asserted-by":"publisher","DOI":"10.2174\/1567201052772915","author":"HAE Benson","year":"2005","unstructured":"Benson HAE (2005) Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv. https:\/\/doi.org\/10.2174\/1567201052772915","journal-title":"Curr Drug Deliv"},{"key":"2208_CR11","doi-asserted-by":"publisher","DOI":"10.26502\/fjhs.258","author":"MA Bin Naime","year":"2025","unstructured":"Bin Naime MA, Ahmed S, Amimul Ihsan M (2025) Efficacy and safety of tsDMARDs vs. bDMARDs in psoriatic arthritis: a systematic review and meta-analysis. Fortune J Health Sci. https:\/\/doi.org\/10.26502\/fjhs.258","journal-title":"Fortune J Health Sci"},{"issue":"4","key":"2208_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.20471\/acc.2022.61.04.04","volume":"61","author":"D Bobek","year":"2022","unstructured":"Bobek D, Stipeti\u0107 AB, Frani\u0107 M, Lucijani\u0107 M, Lucijani\u0107 J, Gra\u010danin AG, Mija\u010dika L, Peri\u0107 P (2022) Use of non-steroidal anti-inflammatory drugs in patients with advanced active rheumatoid arthritis. Acta Clin Croat 61(4):588\u2013598. https:\/\/doi.org\/10.20471\/acc.2022.61.04.04","journal-title":"Acta Clin Croat"},{"key":"2208_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1729135","author":"KR Bonfiglioli","year":"2026","unstructured":"Bonfiglioli KR (2026) From concept to practice: real-world safety of JAK inhibitors in rheumatoid arthritis treatment. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2026.1729135","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2208_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1113\/expphysiol.1991.sp003474","volume":"76","author":"T Brown","year":"1991","unstructured":"Brown T, Laurent U, Fraser (1991) Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 76(1):125\u2013134. https:\/\/doi.org\/10.1113\/expphysiol.1991.sp003474","journal-title":"Exp Physiol"},{"issue":"3","key":"2208_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10717540500455975","volume":"13","author":"MB Brown","year":"2006","unstructured":"Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv 13(3):175\u2013187. https:\/\/doi.org\/10.1080\/10717540500455975","journal-title":"Drug Deliv"},{"issue":"4","key":"2208_CR16","doi-asserted-by":"publisher","first-page":"MR17","DOI":"10.1116\/1.2815690","volume":"2","author":"C Buzea","year":"2007","unstructured":"Buzea C, Pacheco II, Robbie K (2007) Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2(4):MR17\u2013MR71. https:\/\/doi.org\/10.1116\/1.2815690","journal-title":"Biointerphases"},{"issue":"3","key":"2208_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jconrel.2009.10.016","volume":"141","author":"G Cevc","year":"2010","unstructured":"Cevc G, Vierl U (2010) Nanotechnology and the transdermal route. A state-of-the-art review and critical appraisal. J Control Release 141(3):277\u2013299. https:\/\/doi.org\/10.1016\/j.jconrel.2009.10.016","journal-title":"J Control Release"},{"key":"2208_CR18","doi-asserted-by":"publisher","DOI":"10.37532\/1758-4272.2024.19(8).208-211","author":"X Chen","year":"2024","unstructured":"Chen X (2024) Advances in the management of rheumatoid arthritis. Int J Clin Rheumatol. https:\/\/doi.org\/10.37532\/1758-4272.2024.19(8).208-211","journal-title":"Int J Clin Rheumatol"},{"issue":"6","key":"2208_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/rheumatology\/key339","volume":"58","author":"EH Choy","year":"2019","unstructured":"Choy EH (2019) Clinical significance of Janus Kinase inhibitor selectivity. Rheumatology (Oxford) 58(6):953\u2013962. https:\/\/doi.org\/10.1093\/rheumatology\/key339","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2208_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/injr.injr_157_21","volume":"18","author":"R Conway","year":"2023","unstructured":"Conway R, Nikiphorou E (2023) Efficacy and safety of conventional synthetic, biologic, and targeted synthetic DMARDs in RA-ILD: A narrative review. Indian J Rheumatol 18(4):303\u2013311. https:\/\/doi.org\/10.4103\/injr.injr_157_21","journal-title":"Indian J Rheumatol"},{"issue":"1","key":"2208_CR21","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/J.BERH.2024.102019","volume":"39","author":"C Cubberley","year":"2025","unstructured":"Cubberley C, Maharaj A (2025) Global RA treatment recommendations: an update from the various international societies. Best Pract Res Clin Rheumatol 39(1):102019. https:\/\/doi.org\/10.1016\/J.BERH.2024.102019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"2208_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/1744666X.2021.1903319","volume":"17","author":"M Cutolo","year":"2021","unstructured":"Cutolo M, Paolino S, Gotelli E (2021) Glucocorticoids in rheumatoid arthritis are still on the first line: the reasons. Expert Rev Clin Immunol 17(5):417\u2013420. https:\/\/doi.org\/10.1080\/1744666X.2021.1903319","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"2208_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","volume":"158","author":"TK Dash","year":"2012","unstructured":"Dash TK, Konkimalla VB (2012) Poly-\u0454-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release 158(1):15\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.064","journal-title":"J Control Release"},{"key":"2208_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/bmj.316.7134.789","volume":"316","author":"EM Dennison","year":"1998","unstructured":"Dennison EM, Cooper C (1998) Corticosteroids in rheumatoid arthritis. BMJ 316:789\u2013790","journal-title":"BMJ"},{"issue":"12","key":"2208_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.59556\/japi.72.0756","volume":"72","author":"V Dhir","year":"2024","unstructured":"Dhir V, Chiu SM, Gupta R, Phillip SS, Shenoy P, Taksande B, Rawal D, Kumar K, Singh G, Kumar S, Dhuria S, Manovihar A, Bhagat A, Soni C, Jain S, Shobha V (2024) Conventional synthetic disease-modifying drugs remain the mainstay of therapy for rheumatoid arthritis in India. J Assoc Physicians India 72(12):30\u201333. https:\/\/doi.org\/10.59556\/japi.72.0756","journal-title":"J Assoc Physicians India"},{"key":"2208_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2467591","author":"T Dixit","year":"2025","unstructured":"Dixit T, Vaidya A, Ravindran S (2025) Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Future Sci OA. https:\/\/doi.org\/10.1080\/20565623.2025.2467591","journal-title":"Future Sci OA"},{"key":"2208_CR27","unstructured":"Editor James Swarbrick E, Augsburger David E Nichols LL, Breimer DD, Jones TM, Junginger HE, Lee VH, Schulman SG, Skelly Alexandria JP, Felix Theeuwes V, Tucker GT, Welling PG (n.d.) Drugs and the pharmaceutical sciences advisory board"},{"issue":"1","key":"2208_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40005-024-00693-8","volume":"55","author":"SF ELhabal","year":"2025","unstructured":"ELhabal SF, El-Nabarawi MA, Hassanin SO, Hassan FE, Abbas SS, Gebril SM, Albash R (2025) Transdermal fluocinolone acetonide-loaded decorated hyalurosomes cellulose acetate\/polycaprolactone nanofibers mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats. J Pharm Investig 55(1):113\u2013132. https:\/\/doi.org\/10.1007\/s40005-024-00693-8","journal-title":"J Pharm Investig"},{"issue":"2","key":"2208_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.36922\/ijb.8514","volume":"11","author":"FI Fahad","year":"2025","unstructured":"Fahad FI, Ahn M, Kim BS (2025) Advanced 3D-printed microneedle patches for smart drug delivery in wound care. Int J Bioprint 11(2):184\u2013215. https:\/\/doi.org\/10.36922\/ijb.8514","journal-title":"Int J Bioprint"},{"issue":"1","key":"2208_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.30574\/gscbps.2024.28.1.0268","volume":"28","author":"PB Falke","year":"2024","unstructured":"Falke PB, Shelke PG, Hatwar PR, Bakal RL, Kohale NB (2024) A comprehensive review on nanoparticle: characterization, classification, synthesis method, silver nanoparticles, and their applications. GSC Biol Pharm Sci 28(1):171\u2013184. https:\/\/doi.org\/10.30574\/gscbps.2024.28.1.0268","journal-title":"GSC Biol Pharm Sci"},{"issue":"2","key":"2208_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183\u2013196. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.006","journal-title":"Immunity"},{"key":"2208_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, Nicoli S (2021) Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release 332:312\u2013336. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.031","journal-title":"J Control Release"},{"key":"2208_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0016-9","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. https:\/\/doi.org\/10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"key":"2208_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-06030-y","author":"VB Hacholli","year":"2026","unstructured":"Hacholli VB, Patil SM, Szeleszczuk \u0141, Prabhanjan BH, Sindhu H, Shubha MR, Lavanya M, Pramod S, Devi VK, Gackowski M (2026) In vitro development and evaluation of chitosan\u2013cellulose nanocrystal microspheres for controlled dexamethasone delivery in rheumatoid arthritis. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-025-06030-y","journal-title":"Rheumatol Int"},{"key":"2208_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100172","author":"PS Hanmante","year":"2025","unstructured":"Hanmante PS, Lohiya RT, Wankhede AG, Undirwade DS, Lade SN, Burle SS, Umekar MJ (2025) Quantum dot nanotechnology: advancing target drug delivery in oncology. Next Nanotechnol. https:\/\/doi.org\/10.1016\/j.nxnano.2025.100172","journal-title":"Next Nanotechnol"},{"key":"2208_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000536","author":"C Hua","year":"2020","unstructured":"Hua C, Buttgereit F, Combe B (2020) Glucocorticoids in rheumatoid arthritis: current status and future studies. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2017-000536","journal-title":"RMD Open"},{"key":"2208_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/1567201054368020","author":"S Jain","year":"2005","unstructured":"Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK (2005) Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization, and performance evaluation. Curr Drug Deliv. https:\/\/doi.org\/10.2174\/1567201054368020","journal-title":"Curr Drug Deliv"},{"key":"2208_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.128239","author":"G Jamirad","year":"2025","unstructured":"Jamirad G, Seif M, Montazeri A (2025) Fine-tuning hydrophilic\u2013hydrophobic balance in stimuli-responsive PEG-PNIPAM micelles for controlled drug delivery. J Mol Liq. https:\/\/doi.org\/10.1016\/j.molliq.2025.128239","journal-title":"J Mol Liq"},{"issue":"3","key":"2208_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.51248\/v45i3.140","volume":"45","author":"R Jeyarajumanickam","year":"2025","unstructured":"Jeyarajumanickam R, Nayak RP, Chaitra SR, Bhat NP (2025) Cost variation analysis of biological agents (bDMARDs) used in the treatment of rheumatoid arthritis in the Indian market. Biomedicine 45(3):248\u2013252. https:\/\/doi.org\/10.51248\/v45i3.140","journal-title":"Biomedicine"},{"key":"2208_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.149303","author":"V Jhawat","year":"2026","unstructured":"Jhawat V, Chauhan S, Bhutani R, Kapoor G, Bharti S, Singh RP (2026) Hyaluronate-coated TPGS-g-chitosan nanoparticles for rheumatoid arthritis therapy: pharmaceutical development, anti-inflammatory activities, and bone regeneration studies. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149303","journal-title":"Int J Biol Macromol"},{"key":"2208_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01477-8","author":"N Joudeh","year":"2022","unstructured":"Joudeh N, Linke D (2022) Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-022-01477-8","journal-title":"J Nanobiotechnol"},{"key":"2208_CR42","unstructured":"Kalamkar VM, Musmade SR, Ghodke SD, Jori DK (2024) A review of herbal transdermal patches. Int J Novel Res Dev. https:\/\/www.ijnrd.org"},{"issue":"5","key":"2208_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.addr.2003.10.026","volume":"56","author":"YN Kalia","year":"2004","unstructured":"Kalia YN, Naik A, Garrison J, Guy RH (2004) Iontophoretic drug delivery. Adv Drug Deliv Rev 56(5):619\u2013658. https:\/\/doi.org\/10.1016\/j.addr.2003.10.026","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2208_CR44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I (2019) Nanoparticles: properties, applications, and toxicities. Arab J Chem 12(7):908\u2013931. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011","journal-title":"Arab J Chem"},{"issue":"14","key":"2208_CR45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","volume":"64","author":"YC Kim","year":"2012","unstructured":"Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64(14):1547\u20131568. https:\/\/doi.org\/10.1016\/j.addr.2012.04.005","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2208_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10529-006-9219-z","volume":"29","author":"G Kogan","year":"2007","unstructured":"Kogan G, \u0160olt\u00e9s L, Stern R, Gemeiner P (2007) Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 29(1):17\u201325. https:\/\/doi.org\/10.1007\/s10529-006-9219-z","journal-title":"Biotechnol Lett"},{"key":"2208_CR47","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.5281\/zenodo.15480172","volume":"3","author":"A Kumar Varma","year":"2025","unstructured":"Kumar Varma A (2025) |Review. Int J Pharm Sci 3:3599\u20133605. https:\/\/doi.org\/10.5281\/zenodo.15480172","journal-title":"Int J Pharm Sci"},{"key":"2208_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000527","author":"M Kurowska-Stolarska","year":"2017","unstructured":"Kurowska-Stolarska M, Alivernini S (2017) Synovial tissue macrophages: friend or foe? RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2017-000527","journal-title":"RMD Open"},{"key":"2208_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15070800","author":"KA Lee","year":"2025","unstructured":"Lee KA, Kim BY, Kim SS, Cheon YH, Kim SH, Jung JH, Kim GT, Hur JW, Lee MS, Chung CH, Kim YS, Hong SJ, Kim HR, Min HK, Kim SH, Moon SJ, Chang SH, Im S, Nam BD, Kim HS (2025) Impact of csDMARDs vs. b\/tsDMARDs on the prognosis of rheumatoid arthritis-associated interstitial lung disease: a multicenter, retrospective study. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics15070800","journal-title":"Diagnostics"},{"key":"2208_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1385123","author":"J Li","year":"2024","unstructured":"Li J, Li W, Zhuang L (2024) Natural biomimetic nano-system for drug delivery in the treatment of rheumatoid arthritis: a literature review of the last 5 years. Front Med. https:\/\/doi.org\/10.3389\/fmed.2024.1385123","journal-title":"Front Med"},{"issue":"1","key":"2208_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12336\/biomatertransl.2025.01.002","volume":"6","author":"X Li","year":"2025","unstructured":"Li X, Guan Y, Li C, Cheng H, Bai J, Zhao J, Wang Y, Peng J (2025) Recent advances in mitochondrial transplantation to treat disease. Biomater Transl 6(1):4\u201323. https:\/\/doi.org\/10.12336\/biomatertransl.2025.01.002","journal-title":"Biomater Transl"},{"issue":"3","key":"2208_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.15586\/aei.v53i3.1278","volume":"53","author":"D Liu","year":"2025","unstructured":"Liu D, Yu G, Yuan N, Nie D (2025) The efficacy and safety of biologic or targeted synthetic DMARDs in rheumatoid arthritis treatment: one year of review 2024. Allergol Immunopathol Madr 53(3):140\u2013162. https:\/\/doi.org\/10.15586\/aei.v53i3.1278","journal-title":"Allergol Immunopathol Madr"},{"issue":"3","key":"2208_CR53","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) is a biodegradable controlled drug delivery carrier. Polymers (Basel) 3(3):1377\u20131397. https:\/\/doi.org\/10.3390\/polym3031377","journal-title":"Polymers (Basel)"},{"key":"2208_CR54","doi-asserted-by":"publisher","first-page":"386","DOI":"10.37532\/1758","volume":"20","author":"L Martinez","year":"2025","unstructured":"Martinez L (2025) The role of biologics in rheumatoid arthritis: efficacy and safety. Int J Clin Rheumatol 20:386\u2013389. https:\/\/doi.org\/10.37532\/1758","journal-title":"Int J Clin Rheumatol"},{"issue":"1","key":"2208_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.30574\/gscarr.2025.22.1.0014","volume":"22","author":"ND Masane","year":"2025","unstructured":"Masane ND, Rathod AS, Akhand VG, Katekar VA, Deshmukh SP (2025) Nanoparticle-based drug delivery system for cancer therapy. GSC Adv Res Rev 22(1):223\u2013237. https:\/\/doi.org\/10.30574\/gscarr.2025.22.1.0014","journal-title":"GSC Adv Res Rev"},{"key":"2208_CR56","doi-asserted-by":"crossref","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19","DOI":"10.1056\/NEJMra1004965"},{"key":"2208_CR57","doi-asserted-by":"publisher","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P, Piozzi A (2021) Molecular sciences advances in chitosan-based nanoparticles for drug delivery. https:\/\/doi.org\/10.3390\/ijms2217","DOI":"10.3390\/ijms2217"},{"key":"2208_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100837","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Abtahi MS, Hejabi F, Ren Q (2023) Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100837","journal-title":"Mater Today Bio"},{"key":"2208_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9040053","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK (2017) An overview of chitosan nanoparticles and their application in non-parenteral drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics9040053","journal-title":"Pharmaceutics"},{"issue":"7","key":"2208_CR60","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VPK Nell","year":"2004","unstructured":"Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43(7):906\u2013914. https:\/\/doi.org\/10.1093\/rheumatology\/keh199","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"2208_CR61","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1039\/d2ra07863e","volume":"13","author":"MJ Nirmala","year":"2023","unstructured":"Nirmala MJ, Kizhuveetil U, Johnson A, Balaji G, Nagarajan R, Muthuvijayan V (2023) Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv 13(13):8606\u20138629. https:\/\/doi.org\/10.1039\/d2ra07863e","journal-title":"RSC Adv"},{"issue":"4","key":"2208_CR62","first-page":"43","volume":"20","author":"L Opric\u0103","year":"2019","unstructured":"Opric\u0103 L, B\u0103l\u0103\u0219oiu M (2019) Nanoparticles: an overview about their clasifications, synthesis, properties, characterization, and applications. J Exp Mol Biol 20(4):43\u201360","journal-title":"J Exp Mol Biol"},{"issue":"7","key":"2208_CR63","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/acr2.11064","volume":"1","author":"G Ozen","year":"2019","unstructured":"Ozen G, Pedro S, England BR, Mehta B, Wolfe F, Michaud K (2019) Risk of serious infection in patients with rheumatoid arthritis treated with biologic versus nonbiologic disease-modifying antirheumatic drugs. ACR Open Rheumatol 1(7):424\u2013432. https:\/\/doi.org\/10.1002\/acr2.11064","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"2208_CR64","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/REUM.2020.101400","volume":"58","author":"I Padjen","year":"2021","unstructured":"Padjen I, Crnogaj MR, Ani\u0107 B (2021) Conventional disease-modifying agents in rheumatoid arthritis\u2014a review of their current use and role in treatment algorithms. Reumatologia Warsz 58(6):390\u2013400. https:\/\/doi.org\/10.5114\/REUM.2020.101400","journal-title":"Reumatologia Warsz"},{"key":"2208_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029838","author":"M Pang","year":"2022","unstructured":"Pang M, Sun Z, Zhang H (2022) Biologic DMARDs and targeted synthetic DMARDs and the risk of all-cause mortality in rheumatoid arthritis: a systematic review and meta-analysis. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000029838","journal-title":"Medicine"},{"key":"2208_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-025-06363-6","author":"M Pourmadadi","year":"2025","unstructured":"Pourmadadi M, Maleki M, Rahdar A, Aboudzadeh MA (2025) Innovative polymeric and non-polymeric nanocarrier systems for dexamethasone: enhancing precision and reducing side effects. J Nanopart Res. https:\/\/doi.org\/10.1007\/s11051-025-06363-6","journal-title":"J Nanopart Res"},{"key":"2208_CR67","doi-asserted-by":"publisher","DOI":"10.25004\/ijpsdr.2020.120414","author":"ST Prajapati","year":"2020","unstructured":"Prajapati ST, Mandli VA (2020) Formulation development of rotigotine transdermal system using dot-matrix technology. Int J Pharm Sci Drug Res. https:\/\/doi.org\/10.25004\/ijpsdr.2020.120414","journal-title":"Int J Pharm Sci Drug Res"},{"issue":"11","key":"2208_CR68","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261\u20131268. https:\/\/doi.org\/10.1038\/nbt.1504","journal-title":"Nat Biotechnol"},{"key":"2208_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6640103","author":"Preeti","year":"2023","unstructured":"Preeti, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, Saharan R, Kumar S, Geeta SR (2023) Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs. Scientifica. https:\/\/doi.org\/10.1155\/2023\/6640103","journal-title":"Scientifica"},{"issue":"1","key":"2208_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1039\/d4nr03611e","volume":"17","author":"S Priya","year":"2024","unstructured":"Priya S, Jain KK, Daryani J, Desai VM, Kathuria H, Singhvi G (2024) Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward. Nanoscale 17(1):65\u201387. https:\/\/doi.org\/10.1039\/d4nr03611e","journal-title":"Nanoscale"},{"key":"2208_CR71","unstructured":"Puyad S (2025) Nanocarrier-based drug delivery systems: revolutionizing therapeutic efficacy and targeted release. Int J Sci Res Tech. https:\/\/www.ijsrtjournal.com"},{"issue":"6","key":"2208_CR72","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1021\/bm034130m","volume":"4","author":"EI Rabea","year":"2003","unstructured":"Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W (2003) Chitosan as an antimicrobial agent: applications and mode of action. Biomacromol 4(6):1457\u20131465. https:\/\/doi.org\/10.1021\/bm034130m","journal-title":"Biomacromol"},{"key":"2208_CR73","doi-asserted-by":"publisher","first-page":"156307","DOI":"10.1016\/j.prp.2025.156307","volume":"277","author":"V Sabharwal","year":"2026","unstructured":"Sabharwal V, Gulati P, Thakur R, Bala D, Bajaj R, Bansal C, Dhiman T, Verma I, Pannu S (2026) New frontiers in rheumatoid arthritis therapy: from classic DMARDs to biologics and beyond. Pathol Res Pract 277:156307. https:\/\/doi.org\/10.1016\/j.prp.2025.156307","journal-title":"Pathol Res Pract"},{"key":"2208_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.addr.2019.10.004","volume":"153","author":"AH Sabri","year":"2020","unstructured":"Sabri AH, Kim Y, Marlow M, Scurr DJ, Segal J, Banga AK, Kagan L, Lee JB (2020) Intradermal and transdermal drug delivery using microneedles\u2014fabrication, performance evaluation, and application to lymphatic delivery. Adv Drug Deliv Rev 153:195\u2013215. https:\/\/doi.org\/10.1016\/j.addr.2019.10.004","journal-title":"Adv Drug Deliv Rev"},{"key":"2208_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-025-04012-0","author":"S Salathia","year":"2026","unstructured":"Salathia S, Agas D, Gigliobianco MR, Boldrini L, Cappelli A, Casadidio C, Di Martino P, Sabbieti MG, Censi R (2026) Enabling anti-inflammatory activity through hyaluronan-coated PLGA nanoparticles loaded with carvacrol. Pharm Res. https:\/\/doi.org\/10.1007\/s11095-025-04012-0","journal-title":"Pharm Res"},{"issue":"6","key":"2208_CR76","doi-asserted-by":"publisher","first-page":"S760","DOI":"10.1136\/annrheumdis-2019-216653","volume":"79","author":"A Sepriano","year":"2020","unstructured":"Sepriano A, Kerschbaumer A, Smolen JS, Van Der Heijde D, Dougados M, Van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, De Wit M, Falzon L, Landew\u00e9 R (2020) Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 79(6):S760\u2013S770. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216653","journal-title":"Ann Rheum Dis"},{"key":"2208_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1526218","author":"W Shi","year":"2025","unstructured":"Shi W, Liang X, Zhang H, Li H (2025) Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the global burden of disease database. Frontiers Med. https:\/\/doi.org\/10.3389\/fmed.2025.1526218","journal-title":"Frontiers Med"},{"key":"2208_CR78","unstructured":"Singh B, Kumar K, Teotia D (2020) A comprehensive review of matrix type transdermal patches. Eur J Pharm Med Res. https:\/\/www.ejpmr.com"},{"issue":"2","key":"2208_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ph19020218","volume":"19","author":"JJ Skydel","year":"2026","unstructured":"Skydel JJ, Hsiao B (2026) Frontiers in rheumatoid arthritis: emerging research and unmet needs in pharmacologic management. Pharmaceuticals Basel 19(2):218. https:\/\/doi.org\/10.3390\/ph19020218","journal-title":"Pharmaceuticals Basel"},{"issue":"10055","key":"2208_CR80","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"2208_CR81","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA (2019) In the Clinic\u00ae rheumatoid arthritis. Ann Internal Med 170:ITC1\u2013ITC15. https:\/\/doi.org\/10.7326\/AITC201901010","journal-title":"Ann Internal Med"},{"issue":"2","key":"2208_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41584-023-01062-9","volume":"20","author":"Z Szekanecz","year":"2024","unstructured":"Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R (2024) Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol 20(2):101\u2013115. https:\/\/doi.org\/10.1038\/s41584-023-01062-9","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2208_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/17425247.2013.736962","volume":"10","author":"S Thakral","year":"2013","unstructured":"Thakral S, Thakral NK, Majumdar DK (2013) Eudragit\u00ae: A technology evaluation. Expert Opinion Drug Deliv 10(1):131\u2013149. https:\/\/doi.org\/10.1517\/17425247.2013.736962","journal-title":"Expert Opinion Drug Deliv"},{"key":"2208_CR84","unstructured":"Treatment with NSAIDs. (n.d.)."},{"issue":"2","key":"2208_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000091978","volume":"19","author":"H Trommer","year":"2006","unstructured":"Trommer H, Neubert RHH (2006) Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 19(2):106\u2013121. https:\/\/doi.org\/10.1159\/000091978","journal-title":"Skin Pharmacol Physiol"},{"key":"2208_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03943-0","author":"G Unnikrishnan","year":"2023","unstructured":"Unnikrishnan G, Joy A, Megha M, Kolanthai E, Senthilkumar M (2023) Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discover Nano. https:\/\/doi.org\/10.1186\/s11671-023-03943-0","journal-title":"Discover Nano"},{"key":"2208_CR87","unstructured":"Vaishali M, Mahajan R, Vaishali D, Shewale D, Prathamesh M, Raghuwanshi A, Abhay M, Naik S, Shubham M, Sawale G (2025) Transdermal drug delivery systems: advances, challenges, and future professor (guide), 2 principal (guide), 345 student. Int J Sci Dev Res. https:\/\/www.ijsdr.orgb232"},{"issue":"10","key":"2208_CR88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrrheum.2009.182","volume":"5","author":"RF van Vollenhoven","year":"2009","unstructured":"van Vollenhoven RF (2009) Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol 5(10):531\u2013541. https:\/\/doi.org\/10.1038\/nrrheum.2009.182","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2208_CR89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.33545\/26647168.2025.v7.i2b.123","volume":"7","author":"D Varaprada","year":"2025","unstructured":"Varaprada D, Priyanka KB (2025) An updated review on NSAIDs. Int J Pharmacogn Pharm Res 7(2):98\u2013106. https:\/\/doi.org\/10.33545\/26647168.2025.v7.i2b.123","journal-title":"Int J Pharmacogn Pharm Res"},{"key":"2208_CR90","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.biopha.2017.10.109","volume":"97","author":"F Wang","year":"2018","unstructured":"Wang F, He S, Chen B (2018) Retinoic acid-loaded alginate microspheres as a slow-release drug delivery carrier for intravitreal treatment. Biomed Pharmacother 97:722\u2013728. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.109","journal-title":"Biomed Pharmacother"},{"key":"2208_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1547763","author":"L Wei","year":"2025","unstructured":"Wei L, Chen X, Liu M (2025) Global, regional, and national burden and trends of rheumatoid arthritis among the elderly population: an analysis based on the 2021 Global Burden of Disease study. Frontiers Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1547763","journal-title":"Frontiers Immunol"},{"key":"2208_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117219","author":"Y Wendong","year":"2024","unstructured":"Wendong Y, Xingxing Y, Xianze X, Qiaomei F, Yujun S, Shanshan Z, Zheng S, Hairu X (2024) Nanoformulation-assisted microneedle transdermal drug delivery system: an innovative platform enhancing rheumatoid arthritis treatment. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.117219","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2208_CR93","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ (2021) The immunology of rheumatoid arthritis. Nat Immunol 22(1):10\u201318. https:\/\/doi.org\/10.1038\/s41590-020-00816-x","journal-title":"Nat Immunol"},{"key":"2208_CR94","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra040226","author":"AJJ Wood","year":"2004","unstructured":"Wood AJJ, O\u2019Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmra040226","journal-title":"N Engl J Med"},{"key":"2208_CR95","doi-asserted-by":"publisher","first-page":"14253","DOI":"10.2147\/IJN.S553826","volume":"20","author":"Y Xiang","year":"2025","unstructured":"Xiang Y, Pan Z, Tian D, Zhang L, Dang W, Ye J, Xu X, Zhang Q (2025) Recent advances in biomimetic drug delivery for rheumatoid arthritis treatment. Int J Nanomedicine 20:14253\u201314282. https:\/\/doi.org\/10.2147\/IJN.S553826","journal-title":"Int J Nanomedicine"},{"key":"2208_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40429","author":"K Zarei","year":"2024","unstructured":"Zarei K, Jahanbakhshi M, Nahavandi R, Emadi R (2024) Optimized co-delivery of curcumin and methylprednisolone using polyvinyl alcohol-coated CuO nanoparticles for synergistic rheumatoid arthritis treatment. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40429","journal-title":"Heliyon"},{"key":"2208_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106242","volume":"101","author":"MB Zewail","year":"2024","unstructured":"Zewail MB, Asaad GF, Shabana ME, Elbokhomy AS, Elbadry AMM, Riad PY, Salama GA, El-Dakroury WA (2024) PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis. J Drug Deliv Sci Technol 101:106242. https:\/\/doi.org\/10.1016\/j.jddst.2024.106242","journal-title":"J Drug Deliv Sci Technol"},{"key":"2208_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091534","author":"XF Zhang","year":"2016","unstructured":"Zhang XF, Liu ZG, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17091534","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2208_CR99","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/10717544.2022.2089295","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao Z, Chao S, Lu W, Zhang P (2022) Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis. Drug Deliv 29(1):1934\u20131950. https:\/\/doi.org\/10.1080\/10717544.2022.2089295","journal-title":"Drug Deliv"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02208-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:00:07Z","timestamp":1778857207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02208-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}